Iota-Carrageenan enthaltende Zusammensetzung gegen virale Konjunktivitis

Details

Veröffentlichungs-Nr.

EP2898888

Aktenzeichen

EP14152188

Anmeldetag

22. Januar 2014

Veröffentlichung

12. Juni 2019

Erteilung

12. Juni 2019

Rechtsraum

EP

IPC

A61K9/00A61K47/02A61K47/12A61K47/18A61K47/26A61K9/08A61K31/737A61K31/731// A61P31/12

Abstract

The present invention relates to a pharmaceutical composition for use as a medicament in the prophylactic or therapeutic topical treatment of viral eye infections caused by adenovirus of subtype D or influenza A virus of subtype H7. The composition in its ready-for-use formulation comprises iota carrageenan as an active antiviral ingredient and is essentially free of a metal halide salt or contains no more than 0.5% w/v of a metal halide salt.

Anmelder

Firmen

VISUfarma B.V.
Nicox S.A.

Land

🇳🇱 Niederlande

Fachgebiete